Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.47
-0.06 (-0.70%)
Nov 11, 2026, 4:00 PM EST - Market closed
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $55.73 million as of November 11, 2026. It is the 29,145th most valuable company in the world and the 4,493rd biggest in the United States. Its market cap has increased by 33.61% in one year.
Market Cap
55.73M
Enterprise Value
-60.49M
1-Year Change
33.61%
Global Rank
Country Rank
#4,493 United States
Category
ChartMarket Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $55.73M, a decrease of -86.94%. That is a compound annual growth rate of -33.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 55.73M | 65.82% |
| Dec 31, 2025 | 33.61M | -19.94% |
| Dec 31, 2024 | 41.98M | 177.26% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
| Oct 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 59.76M |
| Spero Therapeutics | 59.40M |
| Nordicus Partners | 57.54M |
| RenovoRx | 56.41M |
| Boundless Bio | 55.62M |
| Azora Therapeutics | 54.84M |
| Eloxx Pharmaceuticals | 52.80M |
| Rein Therapeutics | 52.70M |